Predictors of anemia among HIV-infected children on antiretroviral therapy in Wolaita Zone, South Ethiopia: A facility-based cross-sectional study
HIV/AIDS - Research and Palliative Care Jan 12, 2021
Geleta ML, Solomon FB, Tufa EG, et al. - As anemia is detected in the majority of HIV-positive people at some point in the course of the disease, researchers sought to determine the proportion and linked factors of anemia among children on highly active antiretroviral therapy in Wolaita zone, South Ethiopia. They conducted a facility-based cross-sectional study on 256 children (aged 6 months to 14 years) who were on antiretroviral therapy. Of these children, 38.8% were identified as anemic. Anemia was noted in correlation with co-trimoxazole prophylaxis, caregivers not receiving nutritional counseling and presence of intestinal parasites. Based on the findings, they emphasize targeting at appropriate dietary practice, and appropriate hand washing and other hygienic practices to prevent intestinal parasitic infections in health education programs in antiretroviral therapy clinics. All eligible children should be administered co-trimoxazole prophylaxis based on the recommendation.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries